Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Central Nervous System Neoplasms × Azacitidine × Clear all

Phase

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 101 Myelodysplastic Syndromes 69 Leukemia, Myelomonocytic, Chronic 30 Leukemia 29 Neoplasms 10 Carcinoma, Non-Small-Cell Lung 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma, Non-Hodgkin 8 Lymphoma 8 Myeloproliferative Disorders 7 Multiple Myeloma 7 Congenital Abnormalities 7 Leukemia, Myelomonocytic, Acute 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Recurrence 5 Lymphoma, Large B-Cell, Diffuse 5 Lung Neoplasms 5 Leukemia, Monocytic, Acute 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Leukemia, Erythroblastic, Acute 5 Hodgkin Disease 5 Hematologic Neoplasms 5 Anemia, Refractory, with Excess of Blasts 5 Prostatic Neoplasms 4 Primary Myelofibrosis 4 Myelodysplastic-Myeloproliferative Diseases 4 Lymphoma, Follicular 4 Leukemia, Megakaryoblastic, Acute 4 Ovarian Neoplasms 3 Melanoma 3

Interventions

Radiotherapy 76 Temozolomide 71 Carboplatin 29 Filgrastim 28 Vincristine 26 Etoposide 24 Cyclophosphamide 23 Carmustine 23 Irinotecan 20 Chemotherapy, Adjuvant 20 Peripheral Blood Stem Cell Transplantation 18 Cisplatin 17 Lomustine 14 Thiotepa 13 Procarbazine 12 Granulocyte Colony-Stimulating Factor 11 Bevacizumab 11 Thalidomide 10 Surgical Procedures, Operative 10 Magnetic Resonance Spectroscopy 9 Gene Expression Profiling 9 etoposide phosphate 8 Radiation 8 O(6)-benzylguanine 8 Drug Therapy 8 sargramostim 7 Methotrexate 7 Everolimus 7 Busulfan 7 Paclitaxel 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03206021 2024-04-05

COZMOS

The Hospital for Sick Children

Phase 1 Completed

Ependymoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡